Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 4
2014 2
2015 5
2016 7
2017 9
2018 5
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.
Hua CK, Ackerman ME. Hua CK, et al. Front Immunol. 2017 Nov 28;8:1655. doi: 10.3389/fimmu.2017.01655. eCollection 2017. Front Immunol. 2017. PMID: 29234320 Free PMC article. Review.
Systems serology for evaluation of HIV vaccine trials.
Ackerman ME, Barouch DH, Alter G. Ackerman ME, et al. Immunol Rev. 2017 Jan;275(1):262-270. doi: 10.1111/imr.12503. Immunol Rev. 2017. PMID: 28133810 Free PMC article. Review.
Engineering broadly neutralizing antibodies for HIV prevention and therapy.
Hua CK, Ackerman ME. Hua CK, et al. Adv Drug Deliv Rev. 2016 Aug 1;103:157-173. doi: 10.1016/j.addr.2016.01.013. Epub 2016 Jan 29. Adv Drug Deliv Rev. 2016. PMID: 26827912 Free PMC article. Review.
Computationally-driven identification of antibody epitopes.
Hua CK, Gacerez AT, Sentman CL, Ackerman ME, Choi Y, Bailey-Kellogg C. Hua CK, et al. Elife. 2017 Dec 4;6:e29023. doi: 10.7554/eLife.29023. Elife. 2017. PMID: 29199956 Free PMC article.
The role of Fc receptors in HIV prevention and therapy.
Boesch AW, Brown EP, Ackerman ME. Boesch AW, et al. Immunol Rev. 2015 Nov;268(1):296-310. doi: 10.1111/imr.12339. Immunol Rev. 2015. PMID: 26497529 Free PMC article. Review.
Vaccine design: emerging concepts and renewed optimism.
Grimm SK, Ackerman ME. Grimm SK, et al. Curr Opin Biotechnol. 2013 Dec;24(6):1078-88. doi: 10.1016/j.copbio.2013.02.015. Epub 2013 Mar 7. Curr Opin Biotechnol. 2013. PMID: 23474232 Free PMC article. Review.
Opportunities to exploit non-neutralizing HIV-specific antibody activity.
Ackerman ME, Alter G. Ackerman ME, et al. Curr HIV Res. 2013 Jul;11(5):365-77. doi: 10.2174/1570162x113116660058. Curr HIV Res. 2013. PMID: 24191934 Free PMC article. Review.
Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticity.
Lai JI, Eszterhas SK, Brooks SA, Guo C, Zolla-Pazner S, Seaman MS, Bailey-Kellogg C, Griswold KE, Ackerman ME. Lai JI, et al. Vaccine. 2020 Apr 16;38(18):3436-3446. doi: 10.1016/j.vaccine.2020.03.010. Epub 2020 Mar 17. Vaccine. 2020. PMID: 32192810 Free PMC article.
Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life.
Boesch AW, Alter G, Ackerman ME. Boesch AW, et al. Curr Opin HIV AIDS. 2015 May;10(3):160-9. doi: 10.1097/COH.0000000000000149. Curr Opin HIV AIDS. 2015. PMID: 25700208 Free PMC article. Review.
Microscale purification of antigen-specific antibodies.
Brown EP, Normandin E, Osei-Owusu NY, Mahan AE, Chan YN, Lai JI, Vaccari M, Rao M, Franchini G, Alter G, Ackerman ME. Brown EP, et al. J Immunol Methods. 2015 Oct;425:27-36. doi: 10.1016/j.jim.2015.06.005. Epub 2015 Jun 12. J Immunol Methods. 2015. PMID: 26078040 Free PMC article.
32 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page